Neupro
Rotigotine · Patch, Extended Release · Transdermal
No FDA structured label text is available for Neupro. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Rotigotine in 6 products
Neupro NDC products (7)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 50474-801 | Rotigotine 1 mg/24h Patch, Extended Release | UCB, Inc. | NDA |
| 50474-802 | Rotigotine 2 mg/24h Patch, Extended Release | UCB, Inc. | NDA |
| 50474-803 | Rotigotine 3 mg/24h Patch, Extended Release | UCB, Inc. | NDA |
| 50474-804 | Rotigotine 4 mg/24h Patch, Extended Release | UCB, Inc. | NDA |
| 50474-805 | Rotigotine 6 mg/24h Patch, Extended Release | UCB, Inc. | NDA |
| 50474-806 | Rotigotine 8 mg/24h Patch, Extended Release | UCB, Inc. | NDA |
| 50474-808 | Kit | UCB, Inc. | NDA |
Frequently asked questions
Who makes Neupro?
Neupro is listed by 1 labeler in the FDA NDC directory, including UCB, Inc..